Ceftolozane-Tazobactam Treatment of Hypervirulent Multidrug Resistant Pseudomonas Aeruginosa Infections in Neutropenic Patients. Coppola, P., Gaibani, P., Sartor, C., Ambretti, S., Lewis, R., Sassi, C., Pignatti, M., Paolini, S., Curti, A., Castagnetti, F., Ursi, M., Cavo, M., & Stanzani, M. Microorganisms, 8(12):1–11, 2020. Export Date: 20 November 2022 \par Export Date: 20 November 2022
doi  bibtex   
@article{coppola.etal_2020,
  title = {Ceftolozane-Tazobactam Treatment of Hypervirulent Multidrug Resistant Pseudomonas Aeruginosa Infections in Neutropenic Patients},
  author = {Coppola, P.E. and Gaibani, P. and Sartor, C. and Ambretti, S. and Lewis, R.E. and Sassi, C. and Pignatti, M. and Paolini, S. and Curti, A. and Castagnetti, F. and Ursi, M. and Cavo, M. and Stanzani, M.},
  year = {2020},
  journal = {Microorganisms},
  volume = {8},
  number = {12},
  pages = {1--11},
  doi = {10.3390/microorganisms8122055},
  note = {Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/7BSG6JRR/Coppola et al_2020_Ceftolozane-tazobactam treatment of hypervirulent multidrug resistant.pdf}
}

Downloads: 0